Search

everythinglearnresearchcommunity

for

Search:↓

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Physical activity, height, and smoking affect prostate cancer risk.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

The document concludes that accurate diagnosis of ichthyosis is crucial for treatment and genetic advice, and ongoing research is needed for better therapies.

Effective symptom management in IBD improves quality of life and prevents complications.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Dogs with dermatomyositis, especially Collies and Shetland Sheepdogs, need better treatments for their skin and muscle inflammation.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Vitamin D is important for skin health, but more research is needed to understand its full effects and treatment potential.

People with lupus and rheumatoid arthritis have thinner hair than healthy people.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Patients with Discoid Lupus Erythematosus have lower vitamin D and antioxidant levels and higher oxidative stress.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

Fever and rash can be early signs of lupus.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Mitochondrial dysfunction is linked to various skin conditions and could be a target for treatments.

A woman with lupus and systemic sclerosis developed severe acne that didn't improve with treatment and died from pneumonia and septic shock.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

SLE and DM can coexist but are rare and need careful evaluation.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Early identification of lupus through skin signs and blood tests is crucial in India.

No single biomarker is reliable enough for diagnosing and assessing SLE.

COVID-19 vaccines had more side effects and worse perception than flu vaccines in Korean lupus patients.